首页> Diabetes, obesity & metabolism> Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes - a study in both people with type 2 diabetes and healthy subjects

Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes - a study in both people with type 2 diabetes and healthy subjects

导出原文传递

翻译打印收藏纠错

第一作者： Becker,R.H.A.

作者： Becker,R.H.A. ^[1] ; Stechl,J. ^[2] ; Msihid,J. ^[3] ; Kapitza,C.

作者单位： PROFIL, Neuss, Germany ^[1] Sanofi, Paris, France ^[2] Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany ^[3]

关键词 Healthy subjects Insulin response Lixisenatide Pharmacodynamics Pharmacokinetics Type 2 diabetes mellitus

发布时间 2014-09-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Diabetes, obesity & metabolism

2014年16卷9期

793-800页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Diabetes, obesity & metabolism

2014年16卷9期

793-800页

检索历史清除

Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes - a study in both people with type 2 diabetes and healthy subjects

Diabetes, obesity & metabolism

相似文献

同项目论文

Diabetes, obesity & metabolism

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes - a study in both people with type 2 diabetes and healthy subjects

Diabetes, obesity & metabolism

相似文献

同项目论文

Diabetes, obesity & metabolism

相关期刊

检索历史清除